Nitric oxide donors attenuate increase in pressure drop across membrane oxygenators

Perfusion

Volumn 14, Issue 5, 1999, Pages 331-336

  De Somer, F ^a   Foubert, L ^a   Schacht, E ^a   Van Nooten, G ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; MALE; MEMBRANE RESISTANCE; NONHUMAN; OXYGENATOR; PRESSURE; PRIORITY JOURNAL; SWINE;

EID: 0032879762     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765919901400503     Document Type: Article

References (14)

1. Kesteven PJL. Haemostatic changes during cardiopulmonary bypass. Perfusion 1990; 5(suppl.): 9-19.
2. Bearss MG, Ericson D, Parks PJ, Rice R. The puzzling case of the cryoprecipitates. AMSECT Today 1996; 6: 21-25.
3. Groves PH, Penny WJ, Cheadle HA, Lewis MJ. Exogenous nitric oxide inhibits in vivo platelet adhesion following balloon angioplasty. Cardiovasc Res 1992; 26: 615-19.
4. Harris SN, Rinder CS, Rinder HM, Tracey JB, Smith BR, Hines R. Nitroprusside inhibition of platelet function is transient and reversible by catecholamine priming. Anaesthesiology 1995; 83: 1145-52.
5. Konishi R, Shimuzu R, Firestone L et al. Nitric oxide prevents human platelet adhesion to fibre membranes in whole blood. ASAIO J 1996; 42: M850-53.
6. Mellgren K, Friberg LG, Mellgren G, Hedner T, Wenmalm A, Wadenvik H. Nitric oxide in the oxygenator sweep gas reduces platelet activation during experimental perfusion. Ann Thorac Surg 1996; 61: 1194-98.
7. Sly MK, Prager MD, Eberhart RC, Jessen ME, Kulkami PV. Inhibition of surface induced platelet activation by nitric oxide. ASAIO J 1995; 41: M394-98.
8. Videm V, Fosse E, Svennevig JL. Platelet preservation during coronary bypass surgery with bubble and membrane oxygenators: effect of albumin priming. Perfusion 1993; 8: 409-15.
9. Young BR, Lambrecht LK, Cooper SL. Plasma proteins: their role in initiating platelet and fibrin deposition on biomaterials. In: Cooper SL, Peppas NA eds. Biomaterials: interfacial phenomena and applications. Advances in Chemistry Series 199. Washington, DC: American Chemical Society, 1982: 317-50.
10. Jenkins OF, Morris R, Simpson JM. Australian perfusion incident survey. Perfusion 1997; 12: 279-88.
11. Shahbazi T, Jones N, Radomski MW, Moro MA, Gingell D. Nitric oxide donors inhibit platelet spreading on surfaces coated with fibrinogen but not with fibronectin. Thromb Res 1994; 75: 631-42.
12. Kino K, Tsunoo H, Higa Y, Takami M, Hamaguchi H, Nakajima H. Hemoglobin-haptoglobin receptor in rat liver plasma membrane. J Biol Chem 1980; 255: 9616-20.
13. Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996; 42: 1589-600.
14. Pasqui AL, Capecchi PL, Ceccatelli L et al. Nitroprusside in vitro inhibits platelet aggregation and intracellular calcium translocation. Effect of haemoglobin. Thromb Res 1991; 61: 113-22.